Cornelia F Allaart

12.7k total citations · 2 hit papers
189 papers, 7.3k citations indexed

About

Cornelia F Allaart is a scholar working on Rheumatology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Cornelia F Allaart has authored 189 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 164 papers in Rheumatology, 49 papers in Hematology and 46 papers in Pathology and Forensic Medicine. Recurrent topics in Cornelia F Allaart's work include Rheumatoid Arthritis Research and Therapies (156 papers), Systemic Lupus Erythematosus Research (67 papers) and Autoimmune and Inflammatory Disorders Research (46 papers). Cornelia F Allaart is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (156 papers), Systemic Lupus Erythematosus Research (67 papers) and Autoimmune and Inflammatory Disorders Research (46 papers). Cornelia F Allaart collaborates with scholars based in Netherlands, United States and United Kingdom. Cornelia F Allaart's co-authors include T. Huizinga, Ben A. C. Dijkmans, P. J. S. M. Kerstens, Jeska K de Vries‐Bouwstra, H. K. Ronday, Willem F. Lems, Y P M Goekoop-Ruiterman, J.H.L.M. van Groenendael, F. C. Breedveld and K. H. Han and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Cornelia F Allaart

183 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): A randomized, controlled trial

2005 1.1k citations Y P M Goekoop-Ruiterman, Jeska K de Vries‐Bouwstra et al. Arthritis & Rheumatism profile →
Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial

2022 96 citations Marc R. Kok, Stefan Böhringer et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cornelia F Allaart Netherlands	46	6.1k	2.1k	1.3k	1.2k	896	189	7.3k
H. H. Kuper Netherlands	14	5.1k 0.8×	1.9k 0.9×	756 0.6×	1.1k 0.9×	912 1.0×	16	6.0k
M.L.L. Prevoo Netherlands	7	6.0k 1.0×	2.3k 1.1×	890 0.7×	1.2k 1.0×	1.0k 1.1×	10	7.0k
Maya H Buch United Kingdom	42	3.9k 0.6×	1.4k 0.6×	996 0.8×	1.7k 1.5×	1.1k 1.3×	211	6.4k
E. Martín‐Mola Spain	44	4.2k 0.7×	1.5k 0.7×	663 0.5×	1.6k 1.3×	579 0.6×	113	6.0k
Jacek Szechiński Poland	20	3.0k 0.5×	1.1k 0.5×	934 0.7×	1.5k 1.2×	679 0.8×	58	5.0k
Xavier Le Loët France	42	3.3k 0.5×	1.3k 0.6×	644 0.5×	1.4k 1.1×	617 0.7×	198	5.4k
Carl Turesson Sweden	45	4.6k 0.8×	907 0.4×	593 0.4×	1.2k 1.0×	702 0.8×	170	6.6k
L.B.A. van de Putte Netherlands	25	7.7k 1.3×	2.9k 1.4×	1.1k 0.8×	2.2k 1.8×	1.5k 1.6×	80	9.8k
Mary Chester Wasko United States	33	3.4k 0.6×	1.2k 0.6×	606 0.5×	976 0.8×	647 0.7×	64	5.0k
Andrea Rubbert‐Roth Germany	33	3.3k 0.5×	1.5k 0.7×	885 0.7×	1.7k 1.4×	565 0.6×	123	5.1k

Countries citing papers authored by Cornelia F Allaart

Since Specialization

Citations

This map shows the geographic impact of Cornelia F Allaart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornelia F Allaart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornelia F Allaart more than expected).

Fields of papers citing papers by Cornelia F Allaart

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornelia F Allaart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornelia F Allaart. The network helps show where Cornelia F Allaart may publish in the future.

Co-authorship network of co-authors of Cornelia F Allaart

This figure shows the co-authorship network connecting the top 25 collaborators of Cornelia F Allaart. A scholar is included among the top collaborators of Cornelia F Allaart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornelia F Allaart. Cornelia F Allaart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chopra, Arvind, David Vega‐Morales, R Du Toit, et al.. (2025). Rheumatoid arthritis-associated interstitial lung disease in countries across the world. Seminars in Arthritis and Rheumatism. 73. 152719–152719.

Baudoin, Paul, et al.. (2024). Long-term clinical outcomes in early rheumatoid arthritis that was treated-to-target in the BeSt and IMPROVED studies. Lara D. Veeken. 64(3). 1052–1059. 4 indexed citations

Ciaffi, Jacopo, Liesbeth J J Beaart-van de Voorde, Maarten K. Ninaber, et al.. (2023). Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort. RMD Open. 9(2). e002971–e002971. 4 indexed citations

Swen, Jesse J., Alfons A den Broeder, Johanna M W Hazes, et al.. (2023). Genome‐wide Association Study of Methotrexate‐Induced Liver Injury in Rheumatoid Arthritis Patients. Clinical Pharmacology & Therapeutics. 113(4). 916–923. 2 indexed citations

Fehres, Cynthia M., Brigitte A. Wevers, René E. M. Toes, et al.. (2023). Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies. RMD Open. 9(1). e002827–e002827. 5 indexed citations

Bergstra, Sytske Anne, Yvonne P M Goekoop-Ruiterman, Melek Güler-Yüksel, et al.. (2023). Frequency of joint inflammation is associated with local joint damage progression in rheumatoid arthritis despite long-term targeted treatment. RMD Open. 9(1). e002552–e002552. 4 indexed citations

Berg, J. Merlijn van den, Dieneke Schonenberg‐Meinema, Lisette W. A. van Suijlekom‐Smit, et al.. (2023). Patterns of clinical joint inflammation in juvenile idiopathic arthritis. RMD Open. 9(1). e002941–e002941. 5 indexed citations

Boers, Maarten, Linda Hartman, Daniela Opriș-Belinski, et al.. (2023). Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial. Annals of the Rheumatic Diseases. 82(10). 1307–1314. 9 indexed citations

Cessie, Saskia le, Y P M Goekoop-Ruiterman, Melek Güler-Yüksel, et al.. (2023). Long-term mortality in treated-to-target RA and UA: results of the BeSt and IMPROVED cohort. Annals of the Rheumatic Diseases. 83(2). 161–168. 6 indexed citations

10.

Boers, Maarten, Linda Hartman, Daniela Opriș-Belinski, et al.. (2022). Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial. Annals of the Rheumatic Diseases. 81(7). 925–936. 83 indexed citations

11.

Palmowski, Andriko, Frank Buttgereit, Patrick Verschueren, et al.. (2022). Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases. 81(7). 937–943. 15 indexed citations

12.

Hartman, Linda, Maurizio Cutolo, Reinhard Bos, et al.. (2021). Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count. Lara D. Veeken. 60(11). 5239–5246. 7 indexed citations

13.

Ciaffi, Jacopo, Nina Ajmone Marsan, Maarten K. Ninaber, et al.. (2021). New risk model is able to identify patients with a low risk of progression in systemic sclerosis. RMD Open. 7(2). e001524–e001524. 4 indexed citations

14.

Moel, Emma C. de, V. Derksen, Leendert A. Trouw, et al.. (2019). In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response. Arthritis Research & Therapy. 21(1). 28–28. 45 indexed citations

15.

Markusse, I.M., Linda Dirven, Yvonne P M Goekoop-Ruiterman, et al.. (2016). Long-Term Outcomes of Patients With Recent-Onset Rheumatoid Arthritis After 10 Years of Tight Controlled Treatment. Annals of Internal Medicine. 164(8). 2 indexed citations

16.

Hirata, Shintaro, Linda Dirven, Yijing Shen, et al.. (2013). A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study. Lara D. Veeken. 52(7). 1202–1207. 70 indexed citations

17.

Allaart, Cornelia F, et al.. (2012). Randomized Clinical Trial in Pediatric Rheumatology: Are Parents and Patients in Equipoise?. Data Archiving and Networked Services (DANS). 1 indexed citations

18.

Broek, Maries van den, Naomi B. Klarenbeek, Linda Dirven, et al.. (2011). Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study. Annals of the Rheumatic Diseases. 70(8). 1389–1394. 98 indexed citations

19.

Broek, Maries van den, Linda Dirven, Jeska K de Vries‐Bouwstra, et al.. (2011). Rapid Radiological Progression in the First Year of Rheumatoid Arthritis Predicts Both Disability and Radiological Joint Damage Progression Over 8 Years of Targeted Treatment.. Arthritis & Rheumatism. 63(10). 1 indexed citations

20.

Kurreeman, Fina, Leonid Padyukov, Rute B. Marques, et al.. (2007). A Candidate Gene Approach Identifies the TRAF1/C5 Region as a Risk Factor for Rheumatoid Arthritis. PLoS Medicine. 4(9). e278–e278. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact